Annual Total Long Term Liabilities
$50.15 M
+$40.18 M+402.85%
31 December 2023
Summary:
Verona Pharma annual total long term liabilities is currently $50.15 million, with the most recent change of +$40.18 million (+402.85%) on 31 December 2023. During the last 3 years, it has risen by +$45.00 million (+873.96%). VRNA annual total long term liabilities is now at all-time high.VRNA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$223.38 M
+$5.87 M+2.70%
30 September 2024
Summary:
Verona Pharma quarterly total long term liabilities is currently $223.38 million, with the most recent change of +$5.87 million (+2.70%) on 30 September 2024. Over the past year, it has increased by +$203.45 million (+1021.09%). VRNA quarterly long term liabilities is now at all-time high.VRNA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +402.9% | +1021.1% |
| 3 y3 years | +874.0% | +3876.1% |
| 5 y5 years | +3486.4% | +9951.2% |
VRNA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +874.0% | at high | +4275.6% |
| 5 y | 5 years | at high | +7591.6% | at high | >+9999.0% |
| alltime | all time | at high | at high |
Verona Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $223.38 M(+2.7%) |
| June 2024 | - | $217.50 M(+333.7%) |
| Mar 2024 | - | $50.15 M(+0.0%) |
| Dec 2023 | $50.15 M(+402.8%) | $50.15 M(+151.7%) |
| Sept 2023 | - | $19.93 M(+0.2%) |
| June 2023 | - | $19.89 M(+0.1%) |
| Mar 2023 | - | $19.87 M(+99.3%) |
| Dec 2022 | $9.97 M(+93.3%) | $9.97 M(+89.6%) |
| Sept 2022 | - | $5.26 M(+2.9%) |
| June 2022 | - | $5.11 M(+0.2%) |
| Mar 2022 | - | $5.11 M(-1.1%) |
| Dec 2021 | $5.16 M(+0.2%) | $5.16 M(-8.2%) |
| Sept 2021 | - | $5.62 M(-2.1%) |
| June 2021 | - | $5.74 M(+14.0%) |
| Mar 2021 | - | $5.04 M(-2.2%) |
| Dec 2020 | $5.15 M(+689.7%) | $5.15 M(-83.5%) |
| Sept 2020 | - | $31.25 M(+3.1%) |
| June 2020 | - | $30.31 M(+1116.5%) |
| Mar 2020 | - | $2.49 M(+282.1%) |
| Dec 2019 | $652.00 K(-53.4%) | $652.00 K(-70.7%) |
| Sept 2019 | - | $2.22 M(+54.0%) |
| June 2019 | - | $1.44 M(-0.6%) |
| Mar 2019 | - | $1.45 M(+3.8%) |
| Dec 2018 | $1.40 M(+0.7%) | $1.40 M(-0.6%) |
| Sept 2018 | - | $1.41 M(+1.4%) |
| June 2018 | - | $1.39 M(-3.9%) |
| Mar 2018 | - | $1.44 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $1.39 M(+40.3%) | $1.39 M(+21.6%) |
| Sept 2017 | - | $1.14 M(+5.0%) |
| June 2017 | - | $1.09 M(+9.9%) |
| Dec 2016 | $989.50 K(+12.5%) | $989.50 K(>+9900.0%) |
| June 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $879.90 K(>+9900.0%) | $879.90 K(>+9900.0%) |
| June 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| June 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00 | $0.00(0.0%) |
| June 2005 | - | $0.00 |
FAQ
- What is Verona Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Verona Pharma?
- What is Verona Pharma annual total long term liabilities year-on-year change?
- What is Verona Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Verona Pharma?
- What is Verona Pharma quarterly long term liabilities year-on-year change?
What is Verona Pharma annual total long term liabilities?
The current annual total long term liabilities of VRNA is $50.15 M
What is the all time high annual total long term liabilities for Verona Pharma?
Verona Pharma all-time high annual total long term liabilities is $50.15 M
What is Verona Pharma annual total long term liabilities year-on-year change?
Over the past year, VRNA annual total long term liabilities has changed by +$40.18 M (+402.85%)
What is Verona Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of VRNA is $223.38 M
What is the all time high quarterly long term liabilities for Verona Pharma?
Verona Pharma all-time high quarterly total long term liabilities is $223.38 M
What is Verona Pharma quarterly long term liabilities year-on-year change?
Over the past year, VRNA quarterly total long term liabilities has changed by +$203.45 M (+1021.09%)